window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Manufacturing

  • Biomanufacturing,CDMOs & Manufacturing,Drug Development,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow

    Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

    April 17, 2026
  • CDMOs & Manufacturing,Facilities and infrastructure,Manufacturing,Pharmaceuticals and therapeutics

    Symbiosis expands QC capabilities with new 30°C stability chamber

    Symbiosis Pharmaceutical Services has expanded its quality control laboratory in [...]

    April 10, 2026
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    Scaling production of adeno-associated virus vectors remains a key barrier [...]

    April 9, 2026
  • Biologics & Biosimilars,Clinical Trials,Manufacturing,Oncology,Research & Development

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

    April 7, 2026
  • Ingredients,Manufacturing,Packaging,Pharmaceuticals and therapeutics

    BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide

    BIOGRUND and Seprify have introduced a plant-based tablet coating system [...]

    April 7, 2026
  • Diagnostics,Drug discovery,Manufacturing,Research & Development,Technology and platforms

    Thermo Fisher launches Glacios 3 cryo-TEM to expand access to structural biology imaging

    Thermo Fisher Scientific has launched the Thermo Scientific Glacios 3 [...]

    April 2, 2026
  • CDMOs & Manufacturing,Manufacturing,Market Access & Commercialization,Pharmaceuticals and therapeutics

    Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category

    Vetter has been named winner in the Finished Dose category [...]

    March 31, 2026
  • Cell & Gene Therapy,Hematology,Manufacturing,Partnerships & Funding,Rare Diseases,Research & Development,Technology and platforms

    UMass Chan, Caring Cross and Trenchant BioSystems form sickle cell gene therapy manufacturing alliance

    UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

    March 31, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Manufacturing,Partnerships & Funding

    Thermo Fisher and SHL Medical partner on integrated drug-device manufacturing in US

    Thermo Fisher Scientific and SHL Medical partner to integrate fill-finish, [...]

    March 27, 2026
  • CDMOs & Manufacturing,Drug Development,Manufacturing,RNA Therapeutics

    Codexis signs siRNA manufacturing deal for cardiovascular programme

    Codexis has signed an agreement to manufacture siRNA for a [...]

    March 23, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top